|
Meeting Date |
Topic |
Speakers |
Sub-topics |
|
October 5th, 2012 |
Background, Case Study and Approach |
Kate, Lorelei, Joe |
Introduction: The problem, the goal; Lenses (Social Determinants, Genetic, Environmental); |
|
November 9th, 2012 |
Renal Diseasein AI/AN populations |
Dr. AndrewNarva; Dr. Erika Blacksher |
Epidemiology, AI/AN specific information |
|
December 7th, 2012 |
Environment and Occupational Determinants; Toxin Exposures |
Dr. Brooks; Dr. Friedman
|
Epidemic of chronic kidney disease in Mesoamerica: epidemiology and hypotheses Genetic susceptibility as a possible factor in the epidemic of chronic kidney disease in Mesoamerica |
|
February 1st, 2013 |
Leptin-deficiency mouse model of type 2 diabetes and Group Conceptual Integration |
Kelly Hudkins; Group Discussion |
"The goal is reversal of diabetic nephropathy - Can the BTBR ob/ob mouse model help get us there?" Group Case Study Review |
|
March 1st, 2013 |
Understanding Biomarkers involved in Renal Disease Pathways |
Dr. Bryan Kestenbaum; Dr. Chris Simpson |
PTH, FGF23, and measurement error involved in biomarker use |
|
April 5th, 2013 |
Epigeneticsand Fetal Environment |
Dr. Susan Bagby |
Developmental Origins of Disease; Epigenetics, Perinatal Health |
|
May 3rd, 2013 |
Immunology of Renal Disease/CommunityPerspectives |
Moroni Benally |
The Illusion of Collaboration: Cooptation in Collaborative Settings |
|
June 7th, 2013 |
Summary , Conclusions and Deliverables |
Entire Group Discussion |
|